Linking cell function with perfusion: insights from the transcatheter delivery of bone marrow-derived CD133+ cells in ischemic refractory cardiomyopathy trial (RECARDIO).
Beatrice BassettiCorrado CarbucicchioValentina CattoElisa GambiniErica RuraliAlberto BestettiGiuseppe GaipaDaniela BelottiFabrizio CelesteMatteo ParmaStefano RighettiLorenza BiavaMaurizio ArosioAlice BonomiPiergiuseppe AgostoniPaolo ScacciatellaFelice AchilliGiulio PompilioPublished in: Stem cell research & therapy (2018)
ClinicalTrials.gov, NCT02059681 . Registered 11 February 2014.
Keyphrases
- induced apoptosis
- cell cycle arrest
- heart failure
- clinical trial
- study protocol
- phase iii
- mesenchymal stem cells
- phase ii
- endoplasmic reticulum stress
- randomized controlled trial
- oxidative stress
- ischemia reperfusion injury
- signaling pathway
- cell death
- computed tomography
- open label
- cerebral ischemia
- bone marrow
- blood brain barrier